Please login to the form below

Not currently logged in
Email:
Password:

NHS

This page shows the latest NHS news and features for those working in and with pharma, biotech and healthcare.

NICE recommends AstraZeneca’s Imfinzi for adults with non-small cell lung cancer

NICE recommends AstraZeneca’s Imfinzi for adults with non-small cell lung cancer

AstraZeneca (AZ) has announced that the National Institute for Health and Care Excellence (NICE) has approved the routine use of Imfinzi (durvalumab) within NHS England as a monotherapy to treat locally ... Dr Patricia Fisher, consultant clinical

Latest news

More from news
Approximately 386 fully matching, plus 1,837 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 34 fully matching, plus 204 partially matching documents found.

Latest appointments

More from appointments
Approximately 18 fully matching, plus 95 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 53 fully matching, plus 260 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...
Serious about sustainability?
Get to know our new Sustainability Officer here at Cuttsy+Cuttsy...